The Long, Slow Road to Lung Cancer Cure

Affiliations

Editorial

James L Mulshine et al. JAMA Oncol. 2021.

. 2021 Dec 1;7(12):1765-1767.

doi: 10.1001/jamaoncol.2021.4711.

No abstract available

Comment on

Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.
Toumazis I, de Nijs K, Cao P, Bastani M, Munshi V, Ten Haaf K, Jeon J, Gazelle GS, Feuer EJ, de Koning HJ, Meza R, Kong CY, Han SS, Plevritis SK. Toumazis I, et al. JAMA Oncol. 2021 Dec 1;7(12):1833-1842. doi: 10.1001/jamaoncol.2021.4942. JAMA Oncol. 2021. PMID: 34673885 Free PMC article.
Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non-Small Cell Lung Cancer in the US.
Ganti AK, Klein AB, Cotarla I, Seal B, Chou E. Ganti AK, et al. JAMA Oncol. 2021 Dec 1;7(12):1824-1832. doi: 10.1001/jamaoncol.2021.4932. JAMA Oncol. 2021. PMID: 34673888 Free PMC article.